192 related articles for article (PubMed ID: 38542783)
1. Glycomacropeptide as an Efficient Agent to Fight Pathophysiological Mechanisms of Metabolic Syndrome.
Sauvé MF; Feldman F; Sané AT; Koudoufio M; Patey N; Spahis S; Butcher J; Duan H; Figeys D; Marcil V; Stintzi A; Levy E
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542783
[TBL] [Abstract][Full Text] [Related]
2. Dietary delivery of glycomacropeptide within the whey protein matrix is not effective in mitigating tissue ceramide deposition and obesity in mice fed a high-fat diet.
de Hart NMMP; Petrocelli JJ; Nicholson RJ; Yee EM; van Onselen L; Lang MJ; Bourrant PE; Ferrara PJ; Bastian ED; Ward LS; Petersen BL; Drummond MJ
J Dairy Sci; 2024 Feb; 107(2):669-682. PubMed ID: 37709040
[TBL] [Abstract][Full Text] [Related]
3. Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 Cells.
Foisy-Sauvé M; Ahmarani L; Delvin E; Sané AT; Spahis S; Levy E
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32331475
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
[TBL] [Abstract][Full Text] [Related]
6. Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations.
Sauvé MF; Feldman F; Koudoufio M; Ould-Chikh NE; Ahmarani L; Sane A; N'Timbane T; El-Jalbout R; Patey N; Spahis S; Stintzi A; Delvin E; Levy E
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572325
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota induces hepatic steatosis by modulating the T cells balance in high fructose diet mice.
Zhou X; Zhang X; Niu D; Zhang S; Wang H; Zhang X; Nan F; Jiang S; Wang B
Sci Rep; 2023 Apr; 13(1):6701. PubMed ID: 37095192
[TBL] [Abstract][Full Text] [Related]
8. Ameliorating effects of casein glycomacropeptide on obesity induced by high-fat diet in male Sprague-Dawley rats.
Xu SP; Mao XY; Cheng X; Chen B
Food Chem Toxicol; 2013 Jun; 56():1-7. PubMed ID: 23416648
[TBL] [Abstract][Full Text] [Related]
9. The potential efficacy of dietary fatty acids and fructose induced inflammation and oxidative stress on the insulin signaling and fat accumulation in mice.
Tamer F; Ulug E; Akyol A; Nergiz-Unal R
Food Chem Toxicol; 2020 Jan; 135():110914. PubMed ID: 31672515
[TBL] [Abstract][Full Text] [Related]
10. Glycomacropeptide: A Bioactive Milk Derivative to Alleviate Metabolic Syndrome Outcomes.
Foisy Sauvé M; Spahis S; Delvin E; Levy E
Antioxid Redox Signal; 2021 Jan; 34(3):201-222. PubMed ID: 32338040
[No Abstract] [Full Text] [Related]
11. Erica multiflora extract rich in quercetin-3-O-glucoside and kaempferol-3-O-glucoside alleviates high fat and fructose diet-induced fatty liver disease by modulating metabolic and inflammatory pathways in Wistar rats.
Khlifi R; Dhaouefi Z; Toumia IB; Lahmar A; Sioud F; Bouhajeb R; Bellalah A; Chekir-Ghedira L
J Nutr Biochem; 2020 Dec; 86():108490. PubMed ID: 32920086
[TBL] [Abstract][Full Text] [Related]
12. Myristic Acid Supplementation Aggravates High Fat Diet-Induced Adipose Inflammation and Systemic Insulin Resistance in Mice.
Saraswathi V; Kumar N; Ai W; Gopal T; Bhatt S; Harris EN; Talmon GA; Desouza CV
Biomolecules; 2022 May; 12(6):. PubMed ID: 35740864
[TBL] [Abstract][Full Text] [Related]
13. Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice.
Anhê FF; Varin TV; Le Barz M; Pilon G; Dudonné S; Trottier J; St-Pierre P; Harris CS; Lucas M; Lemire M; Dewailly É; Barbier O; Desjardins Y; Roy D; Marette A
Diabetologia; 2018 Apr; 61(4):919-931. PubMed ID: 29270816
[TBL] [Abstract][Full Text] [Related]
14. Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced metabolic-associated fatty liver disease via upregulation of Nrf2/HO-1 expressions in C57BL/6J mice.
Wayal V; Hsieh CC
Biomed Pharmacother; 2023 Dec; 168():115724. PubMed ID: 37852102
[TBL] [Abstract][Full Text] [Related]
15. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
[TBL] [Abstract][Full Text] [Related]
16. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
[TBL] [Abstract][Full Text] [Related]
17. Differential Effects of Dietary Fat Content and Protein Source on Bone Phenotype and Fatty Acid Oxidation in Female C57Bl/6 Mice.
Sawin EA; Stroup BM; Murali SG; O'Neill LM; Ntambi JM; Ney DM
PLoS One; 2016; 11(10):e0163234. PubMed ID: 27695036
[TBL] [Abstract][Full Text] [Related]
18. Chronic psychological stress and high-fat high-fructose diet disrupt metabolic and inflammatory gene networks in the brain, liver, and gut and promote behavioral deficits in mice.
de Sousa Rodrigues ME; Bekhbat M; Houser MC; Chang J; Walker DI; Jones DP; Oller do Nascimento CMP; Barnum CJ; Tansey MG
Brain Behav Immun; 2017 Jan; 59():158-172. PubMed ID: 27592562
[TBL] [Abstract][Full Text] [Related]
19. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats.
Crescenzo R; Bianco F; Coppola P; Mazzoli A; Tussellino M; Carotenuto R; Liverini G; Iossa S
Exp Physiol; 2014 Sep; 99(9):1203-13. PubMed ID: 24972835
[TBL] [Abstract][Full Text] [Related]
20. Saskatoon berry powder reduces hepatic steatosis and insulin resistance in high fat-high sucrose diet-induced obese mice.
Zhao R; Xiang B; Dolinsky VW; Xia M; Shen GX
J Nutr Biochem; 2021 Sep; 95():108778. PubMed ID: 34004342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
